Table 1

Demographics and clinical characteristics among outpatients with COVID-19 monitored with home oxygen saturation devices

Demographic informationNo (%)
Total no89
Age, median (IQR), years52 (38–64)
Sex
 Female57(64)
 Male32 (36)
Pregnant6 (7)
Days from symptom onset to clinical assessment, median (IQR)6 (3–8)
Comorbidities
 Cardiac disease7 (8)
 Chronic lung disease3 (3)
 Asthma14 (16)
 Chronic kidney disease7 (8)
 Moderate/severe liver disease2 (2)
 Chronic neurological issues5 (6)
 Malignancy14 (16)
 Chronic haematological disease7 (8)
 Diabetes15 (17)
 Hypertension32 (36)
 Rheumatic disorder3 (3)
 Malnutrition1 (1)
 Obesity18 (20)
 None29 (33)
Signs and symptoms on intake assessment
 Fever35 (39)
 Sore throat28 (31)
 Runny nose29 (33)
 Cough56 (63)
 Shortness of breath23 (26)
 Chills/rigours30 (34)
 Conjunctivitis10 (11)
 Ear pain7 (8)
 Anosmia21 (24)
 Dysgeusia25 (28)
 Sputum10 (11)
 Hemoptysis0
 Wheezing7 (8)
 Chest pain19 (21)
 Myalgia40 (45)
 Arthralgia16 (18)
 Abdominal pain14 (16)
 Nausea/vomiting22 (25)
 Diarrhoea25 (28)
 Adenopathy0
 Rash1 (1)
 Fatigue/malaise59 (66)
 Headache37 (42)
 Confusion5 (6)
 Depression/anxiety15 (17)
 Insomnia19 (21)
 Anorexia33 (37)
Laboratory findings at admission, median (IQR)
 Leukocytes, x109/L (n=21)5.9 (4.2–7.5)
 Lymphocytes, x109/L (n=21)1.1 (0.6–1.3)
 Lactate Dehydrogenase, IU/L (n=4)216.0 (63.4–277.0)
 D-dimer, mcg/L (n=5)906.0 (555.0–1082.5)
 High-sensitivity Troponin T ng/L (n=11)9.7 (6.0–10.0)
 Ferritin, mcg/L (n=3)1644.0 (153.5–2082.5)
Chest radiography done29 (33)
 Abnormal23 (26)
 Bilateral infiltrates18 (20)
Outcome
 ICU admission5 (6)
 Length of ICU stay, median (IQR), days6 (2–11)
 Intubation1 (1)
 Duration of intubation, days15 (17)
 Hospitalisation11 (12)
 Duration of hospitalisation, median (IQR), days3 (2.5–7)
 Multiple hospitalisations2 (2)
 Death (within 30 days of diagnosis)0
  • ICU, intensive care unit.